SUKENAGA Yoshikazu | Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd
スポンサーリンク
概要
関連著者
-
SUKENAGA Yoshikazu
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd
-
Sukenaga Yoshikazu
Research & Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Sukenaga Y
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Tsuchiya Kouichi
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
TAKAYASU Yoshiyuki
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.
-
Takayasu Yoshiyuki
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Takai Shinji
Department Of Cardiology Kouseikai Takeda Hospital
-
MIYAZAKI Mizuo
Department of Pharmacology, Osaka Medical College
-
Iida M
Biosafety Res. Center Shizuoka Jpn
-
Takai Shinji
Department Of Pharmacology Osaka Medical College
-
HOSONO Makoto
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.,
-
Iida Masashi
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd
-
Hosono Makoto
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd
-
FUJITA Naomi
Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd
-
KAMOSHITA Keiichi
Research & Development Division, Pharmaceuticals Group, Nippon Kayaku Co., Ltd.
-
Fujita Naomi
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd
-
Aoyama Takayuki
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Miyazaki Mizuo
Department Of Pharmacoldgy Osaka Medical College
-
Kamoshita Keiichi
Research & Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Takai Shinji
Department Of Animal Hygiene School Of Veterinary Medicine And Animal Sciences Kitasato University
著作論文
- Development of the Chymase Inhibitor as an Anti-Tissue-Remodeling Drug : Myocardial Infarction and Some Other Possibilities
- Bronchodilator and Cardiovascular Effects of NKH477, a Novel Water-Soluble Forskolin Derivative, in Guinea Pigs
- Oxidative Modification of NK30424A and B Enhance Inhibitory Effect on Lipopolysaccharide-induced Tumour Necrosis Factor-α Promoter Activity
- NK30424A and B, Novel Inhibitors of Lipopolysaccharide-induced Tumour Necrosis Factor Alpha Production, Produced by Streptomyces sp. NA30424